{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:49:33Z","timestamp":1792590573295,"version":"4.5.0"},"reference-count":34,"publisher":"MyJove Corporation","issue":"228","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69927","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:02:07Z","timestamp":1770163327000},"source":"Crossref","is-referenced-by-count":0,"title":["Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models"],"prefix":"10.3791","author":[{"given":"Katarzyna","family":"Kempinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane L.","family":"Mallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katlyn","family":"Pavlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitra","family":"Kommaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejaswini","family":"Sivalokanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Kiupel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik M.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo F.","family":"Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"1","key":"ref1","first-page":"12","type":"journal-article","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N., Jemal, A. Cancer statistics, 2024. CA Cancer J Clin. 74 (1), 12-49 (2024).","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajpath.2018.09.009","type":"journal-article","article-title":"The paradoxical web of pancreatic cancer tumor microenvironment","volume":"189","author":"Lafaro","year":"2019","unstructured":"Lafaro, K. J., Melstrom, L. G. The paradoxical web of pancreatic cancer tumor microenvironment. Am J Pathol. 189 (1), 44-57 (2019).","journal-title":"Am J Pathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","type":"journal-article","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","unstructured":"Kleeff, J. et al. Pancreatic cancer. Nat Rev Dis Primers. 2, 16022 (2016).","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","type":"journal-article","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","unstructured":"Collisson, E. A., Bailey, P., Chang, D. K., Biankin, A. V. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 16 (4), 207-220 (2019).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ijc.11281","type":"journal-article","article-title":"Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer","volume":"106","author":"Grimm","year":"2003","unstructured":"Grimm, J., Potthast, A., Wunder, A., Moore, A. Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer. Int J Cancer. 106 (5), 806-811 (2003).","journal-title":"Int J Cancer"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41416-019-0495-5","type":"journal-article","article-title":"The role of mouse tumour models in the discovery and development of anticancer drugs","volume":"121","author":"Ireson","year":"2019","unstructured":"Ireson, C. R., Alavijeh, M. S., Palmer, A. M., Fowler, E. R., Jones, H. J. The role of mouse tumour models in the discovery and development of anticancer drugs. Br J Cancer. 121 (2), 101-108 (2019).","journal-title":"Br J Cancer"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/PPO.0b013e31827ab4c4","type":"journal-article","article-title":"Genetically engineered mouse models of pancreatic cancer","volume":"18","author":"Westphalen","year":"2012","unstructured":"Westphalen, C. B., Olive, K. P. Genetically engineered mouse models of pancreatic cancer. Cancer J. 18 (6), 502-510 (2012).","journal-title":"Cancer J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0076-6879(07)00406-5","type":"journal-article","article-title":"K-ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses","volume":"439","author":"Cook","year":"2008","unstructured":"Cook, N., Olive, K. P., Frese, K., Tuveson, D. A. K-ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses. Methods Enzymol. 439, 73-85 (2008).","journal-title":"Methods Enzymol"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/ijc.33041","type":"journal-article","article-title":"Loss of microRNA-21 leads to profound stromal remodeling and short survival in K-ras-driven mouse models of pancreatic cancer","volume":"147","author":"Schipper","year":"2020","unstructured":"Schipper, J. et al. Loss of microRNA-21 leads to profound stromal remodeling and short survival in K-ras-driven mouse models of pancreatic cancer. Int J Cancer. 147 (8), 2265-2278 (2020).","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"102070","DOI":"10.1016\/j.ctrv.2020.102070","type":"journal-article","article-title":"KRAS: from undruggable to a druggable cancer target","volume":"89","author":"Uprety","year":"2020","unstructured":"Uprety, D., Adjei, A. A. KRAS: from undruggable to a druggable cancer target. Cancer Treat Rev. 89, 102070 (2020).","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","type":"journal-article","article-title":"Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer","volume":"17","author":"Buscail","year":"2020","unstructured":"Buscail, L., Bournet, B., Cordelier, P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 17 (3), 153-168 (2020).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2407-9-106","type":"journal-article","article-title":"Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer","volume":"9","author":"Snyder","year":"2009","unstructured":"Snyder, C. S. et al. Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer. BMC Cancer. 9, 106 (2009).","journal-title":"BMC Cancer"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/cam4.1062","type":"journal-article","article-title":"Noninvasive characterization of pancreatic tumor mouse models using magnetic resonance imaging","volume":"6","author":"Farr","year":"2017","unstructured":"Farr, N. et al. Noninvasive characterization of pancreatic tumor mouse models using magnetic resonance imaging. Cancer Med. 6 (5), 1082-1090 (2017).","journal-title":"Cancer Med"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5662\/wjm.v7.i3.101","type":"journal-article","article-title":"Pancreatic imaging: current status of clinical practices and small animal studies","volume":"7","author":"Yin","year":"2017","unstructured":"Yin, T., Liu, Y., Peeters, R., Feng, Y., Ni, Y. Pancreatic imaging: current status of clinical practices and small animal studies. World J Methodol. 7 (3), 101-107 (2017).","journal-title":"World J Methodol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41598-021-03684-z","type":"journal-article","article-title":"Validation of a combined ultrasound and bioluminescence imaging system with magnetic resonance imaging in orthotopic pancreatic murine tumors","volume":"12","author":"Rojas","year":"2022","unstructured":"Rojas, J. D. et al. Validation of a combined ultrasound and bioluminescence imaging system with magnetic resonance imaging in orthotopic pancreatic murine tumors. Sci Rep. 12 (1), 102 (2022).","journal-title":"Sci Rep"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40644-018-0172-6","type":"journal-article","article-title":"Evaluation of pancreatic tumor development in KPC mice using multiparametric MRI","volume":"18","author":"Vohra","year":"2018","unstructured":"Vohra, R. et al. Evaluation of pancreatic tumor development in KPC mice using multiparametric MRI. Cancer Imaging. 18 (1), 41 (2018).","journal-title":"Cancer Imaging"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1158\/0008-5472.CAN-20-0373","type":"journal-article","article-title":"Preclinical applications of multi-platform imaging in animal models of cancer","volume":"81","author":"Serkova","year":"2021","unstructured":"Serkova, N. J. et al. Preclinical applications of multi-platform imaging in animal models of cancer. Cancer Res. 81 (5), 1189-1200 (2021).","journal-title":"Cancer Res"},{"issue":"48","key":"ref18","first-page":"e2497","type":"journal-article","article-title":"Multiple-mouse neuroanatomical magnetic resonance imaging","author":"Dazai","year":"2011","unstructured":"Dazai, J., Spring, S., Cahill, L. S., Henkelman, R. M. Multiple-mouse neuroanatomical magnetic resonance imaging. J Vis Exp. (48), e2497 (2011).","journal-title":"J Vis Exp"},{"issue":"6378","key":"ref19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1126\/science.aaq1067","type":"journal-article","article-title":"Single-cell bioluminescence imaging of deep tissue in freely moving animals","volume":"359","author":"Iwano","year":"2018","unstructured":"Iwano, S. et al. Single-cell bioluminescence imaging of deep tissue in freely moving animals. Science. 359 (6378), 935-939 (2018).","journal-title":"Science"},{"issue":"1","key":"ref20","first-page":"1","type":"journal-article","article-title":"Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer","volume":"40","author":"Sempere","year":"2021","unstructured":"Sempere, L. F., Powell, K., Rana, J., Brock, A. A., Schmittgen, T. D. Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer. Cancer Metastasis Rev. 40 (1), 1-20 (2021).","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/cancers14061588","type":"journal-article","article-title":"Clinical applications of short non-coding RNA-based therapies in the era of precision medicine","volume":"14","author":"Smith","year":"2022","unstructured":"Smith, E. S. et al. Clinical applications of short non-coding RNA-based therapies in the era of precision medicine. Cancers (Basel). 14 (6), 1588 (2022).","journal-title":"Cancers (Basel)"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/cancers9070071","type":"journal-article","article-title":"Exosomal microRNAs in breast cancer towards diagnostic and therapeutic applications","volume":"9","author":"Sempere","year":"2017","unstructured":"Sempere, L. F., Keto, J., Fabbri, M. Exosomal microRNAs in breast cancer towards diagnostic and therapeutic applications. Cancers (Basel). 9 (7), 71 (2017).","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1662","DOI":"10.1002\/wrna.1662","type":"journal-article","article-title":"MicroRNA-based diagnostic and therapeutic applications in cancer medicine","volume":"12","author":"Sempere","year":"2021","unstructured":"Sempere, L. F., Azmi, A. S., Moore, A. MicroRNA-based diagnostic and therapeutic applications in cancer medicine. Wiley Interdiscip Rev RNA. 12, e1662 (2021).","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"24","key":"ref24","doi-asserted-by":"crossref","first-page":"e202400491","DOI":"10.1002\/cmdc.202400491","type":"journal-article","article-title":"Tumor-associated carbohydrate antigen 19-9 (CA 19-9), a promising target for antibody-based detection, diagnosis, and immunotherapy of cancer","volume":"19","author":"Nakisa","year":"2024","unstructured":"Nakisa, A. et al. Tumor-associated carbohydrate antigen 19-9 (CA 19-9), a promising target for antibody-based detection, diagnosis, and immunotherapy of cancer. ChemMedChem. 19 (24), e202400491 (2024).","journal-title":"ChemMedChem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"104740","DOI":"10.1016\/j.phrs.2020.104740","type":"journal-article","article-title":"Developing effective combination therapy for pancreatic cancer: an overview","volume":"155","author":"Miller","year":"2020","unstructured":"Miller, A. L., Garcia, P. L., Yoon, K. J. Developing effective combination therapy for pancreatic cancer: an overview. Pharmacol Res. 155, 104740 (2020).","journal-title":"Pharmacol Res"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","type":"journal-article","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","unstructured":"Dreyer, S. B., Beer, P., Hingorani, S. R., Biankin, A. V. Improving outcomes of patients with pancreatic cancer. Nat Rev Clin Oncol. 22 (6), 439-456 (2025).","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","type":"journal-article","article-title":"From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer","volume":"17","author":"Nevala-Plagemann","year":"2020","unstructured":"Nevala-Plagemann, C., Hidalgo, M., Garrido-Laguna, I. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer. Nat Rev Clin Oncol. 17 (2), 108-123 (2020).","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3390\/cancers14102486","type":"journal-article","article-title":"Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review","volume":"14","author":"Koltai","year":"2022","unstructured":"Koltai, T. et al. Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review. Cancers (Basel). 14 (10), 2486 (2022).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00873232","type":"journal-article","article-title":"Phase II trial of gemcitabine (2,2\u2032-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas","volume":"12","author":"Casper","year":"1994","unstructured":"Casper, E. S. et al. Phase II trial of gemcitabine (2,2\u2032-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs. 12 (1), 29-34 (1994).","journal-title":"Invest New Drugs"},{"issue":"3 Suppl","key":"ref30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3+<633::AID-CNCR8>3.0.CO;2-B","type":"journal-article","article-title":"Activity of gemcitabine in patients with advanced pancreatic carcinoma: a review","volume":"78","author":"Moore","year":"1996","unstructured":"Moore, M. Activity of gemcitabine in patients with advanced pancreatic carcinoma: a review. Cancer. 78 (3 Suppl), 633-638 (1996).","journal-title":"Cancer"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"e001367","DOI":"10.1136\/jitc-2020-001367","type":"journal-article","article-title":"Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis","volume":"8","author":"Ho","year":"2020","unstructured":"Ho, T. T. B. et al. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis. J Immunother Cancer. 8 (2), e001367 (2020).","journal-title":"J Immunother Cancer"},{"issue":"6 Suppl","key":"ref32","type":"journal-article","article-title":"Genetic ablation of microRNA-10b improves treatment outcomes in mouse models of pancreatic cancer","volume":"84","author":"Kempinska","year":"2024","unstructured":"Kempinska, K. et al. Genetic ablation of microRNA-10b improves treatment outcomes in mouse models of pancreatic cancer. Cancer Res. 84 (6 Suppl), Abstract 467 (2024).","journal-title":"Cancer Res"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11307-025-02009-0","type":"journal-article","article-title":"Species-specific hepatic uptake of [64Cu]Cu-EOB-NOTA, a newly designed hepatospecific PET agent","volume":"27","author":"Fan","year":"2025","unstructured":"Fan, J. et al. Species-specific hepatic uptake of [64Cu]Cu-EOB-NOTA, a newly designed hepatospecific PET agent. Mol Imaging Biol. 27 (3), 305-312 (2025).","journal-title":"Mol Imaging Biol"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mrm.22236","type":"journal-article","article-title":"Multiple-mouse MRI with multiple arrays of receive coils","volume":"63","author":"Ramirez","year":"2010","unstructured":"Ramirez, M. S., Esparza-Coss, E., Bankson, J. A. Multiple-mouse MRI with multiple arrays of receive coils. Magn Reson Med. 63 (3), 803-810 (2010).","journal-title":"Magn Reson Med"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/69927\/multianimal-magnetic-resonance-imaging-for-tumor-measurements","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:27:57Z","timestamp":1792589277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69927\/multianimal-magnetic-resonance-imaging-for-tumor-measurements"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":34,"journal-issue":{"issue":"228","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/69927","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}